Northrop Grumman stock gains on Guggenheim buy call and $4.8 billion Army contract
Published on 09/16/2026 at 14:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Northrop Grumman stock (ISIN US6668071029) closed at USD 527.90 on the NYSE on September 15, 2026, up 1.72% from the prior session and leaving the shares roughly 16% below a new analyst price target of USD 612. According to Investing.com on September 15, 2026, Guggenheim began coverage of the defense contractor with a Buy rating and a USD 612 price target, signaling further upside potential for investors.
Guggenheim’s Buy rating lifts sentiment
As Investing.com reports, Guggenheim sees about 18% potential upside for Northrop Grumman at its USD 612 price target, compared with the recent closing level near USD 528, framing the stock as a beneficiary of rising US defense spending. The Guggenheim note came as broader US equity indices traded under pressure around September 15, 2026, but it helped underpin interest in large defense names with diversified backlogs and exposure to strategic missile and aerospace programs.
MarketBeat data cited in a recent overview listed Northrop Grumman’s consensus price target at roughly USD 662.25, implying that the new USD 612 Guggenheim target sits below the broader analyst average but still points to double-digit upside from the latest NYSE close. According to StockInvest.us, the shares have shown mixed technical signals in recent months, and a fresh fundamental call from a major research house adds a new anchor for sentiment.
$4.8 billion Army contract and raised 2026 guidance
Beyond the analyst call, fundamentals have moved in Northrop Grumman’s favor. The US Army awarded the company a USD 4.8 billion contract for its Common Infrared Countermeasure (CIRCM) system, a key survivability technology for rotary-wing and fixed-wing aircraft. As Yahoo Finance reported on September 15, 2026, the CIRCM award lifted Northrop Grumman’s total backlog to a record USD 104.7 billion, underscoring the long-term revenue visibility embedded in its defense portfolio.
The contract news came alongside updated full-year 2026 guidance. According to Yahoo Finance, Northrop Grumman raised its 2026 sales outlook to a range of USD 43.8 billion to USD 44.3 billion, up from a prior band of USD 43.5 billion to USD 44.0 billion, marking an increase of up to USD 0.8 billion at the top end. The company also lifted its MTM-adjusted earnings per share guidance to USD 28.60 to USD 29.10 for 2026, compared with an earlier range that was lower, while maintaining adjusted free cash flow guidance in a corridor of USD 3.1 billion to USD 3.5 billion.
For investors, the combination of a record USD 104.7 billion backlog and higher 2026 sales and EPS guidance provides a concrete quantitative backdrop to Guggenheim’s positive stance. The backlog figure reflects contracted work to be performed over multiple years, and the guidance increase indicates management confidence that awards like the USD 4.8 billion CIRCM program will translate into tangible top-line and bottom-line growth within the current planning horizon.
Valuation views and recent trading behavior
Valuation-oriented analysis has started to incorporate the new contract and guidance changes. A recent piece from Simply Wall St on September 16, 2026, estimated Northrop Grumman’s fair value at around USD 643.62 per share based on a discounted cash flow approach. Against a last close of about USD 531.25 referenced in that analysis, the implied upside of roughly USD 112.37, or around 21.1%, supports the narrative that the stock may be undervalued when set against its long-term cash generation prospects.
Even with these supportive valuations, Simply Wall St noted that Northrop Grumman’s share price had fallen about 9.3% over the past month and year to date, reflecting choppy trading despite a five-year total shareholder return of 66.9%. According to Simply Wall St, this divergence between near-term volatility and longer-run returns illustrates how contract wins and backlog growth can take time to be fully reflected in the share price.
From an investor perspective, the quantified signals are clear: a record backlog of USD 104.7 billion, 2026 sales guidance raised by up to USD 0.3 billion at the midpoint, and MTM-adjusted EPS expected to reach up to USD 29.10 all provide concrete metrics that can be weighed against the stock’s recent pullback and the various analyst targets ranging from USD 612 at Guggenheim to around USD 662 on a consensus basis.
Operational milestones add to long-term story
Beyond contracts and guidance, program execution remains central to Northrop Grumman’s thesis. A market radar note from Moomoo on September 16, 2026, highlighted that Northrop Grumman had completed a key assembly milestone on its Sentinel intercontinental ballistic missile program, a cornerstone modernization effort for the US strategic deterrent. While the note did not attach specific revenue figures to the milestone, it reinforces the company’s role in high-priority, multi-decade defense projects whose value is embedded in the USD 104.7 billion backlog.
In the same defense sector context, Newsminimalist reported on September 16, 2026, that Guggenheim’s broader sector work envisions US defense budgets potentially trending toward USD 1 trillion, with Buy ratings assigned to several large-cap names including Northrop Grumman. For shareholders, that macro view connects directly to the company’s raised 2026 sales guidance band, as sustained budget growth would support continued order intake beyond the USD 4.8 billion CIRCM award already secured.
The risk side of the ledger is not absent. As Yahoo Finance noted, execution is the bigger test for large, complex programs like CIRCM and Sentinel, where schedule, cost and performance milestones must be met over many years. Any slippage could impact margins and cash flows, even with a strong contractual base.
Northrop Grumman stock and current market levels
Northrop Grumman’s primary listing is on the NYSE under the ticker NOC. Per recent NYSE data summarized in market overviews, the shares closed at USD 527.90 on September 15, 2026, after gaining USD 8.93, or 1.72%, on the day, with trading volume aligned with typical levels for the defense group. At that closing price, the implied market capitalization stands in the tens of billions of dollars, reflecting the company’s status as a major component of the US defense sector and a member of the S&P 500 index.
While exact 52-week high and low levels were not detailed in the latest week-filtered summaries, the recent closing price near USD 528, combined with the referenced fair value estimate of USD 643.62 from Simply Wall St and the consensus target of around USD 662.25, indicates that Northrop Grumman stock currently trades meaningfully below many valuation anchors as of mid-September 2026. For investors, the interplay between a record USD 104.7 billion backlog, raised 2026 guidance and fresh Buy-rated analyst coverage now frames the key question of how quickly those fundamentals will be reflected in the share price.
Northrop Grumman stock key data
- Company: Northrop Grumman Corporation
- ISIN: US6668071029
- Ticker: NOC
- Trading venue: NYSE
- Price (as of September 15, 2026): 527.90 USD
- Market capitalization: [value] USD (as of September 15, 2026)
- Sector / Industry: Aerospace and Defense
- Index membership: S&P 500
